Approval · Notice of Compliance 20723 · 2018
PREGABALIN: Notice of Compliance 20723
Issued April 10, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20723
- Date
- April 10, 2018
- Company
- Altamed PharmaBoucherville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Canadian reference product
- LYRICA (Pfizer Canada Ulc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREGABALIN | 02474352 | Marketed |
| PREGABALIN | 02474360 | Marketed |
| PREGABALIN | 02474379 | Marketed |
| PREGABALIN | 02474387 | Marketed |
Medicinal ingredients
- PREGABALIN 25 MG per CAP
- PREGABALIN 50 MG per CAP
- PREGABALIN 75 MG per CAP
- PREGABALIN 150 MG per CAP